CUBIST PHARMACEUTICALS INC's ticker is CBST and the CUSIP is 229678107. A total of 276 filers reported holding CUBIST PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $5,485,000 | +56.3% | 54,500 | +3.0% | 0.02% | +47.1% |
| Q3 2014 | $3,509,000 | -39.8% | 52,900 | -36.6% | 0.02% | -39.3% |
| Q2 2014 | $5,830,000 | +23.8% | 83,500 | +29.7% | 0.03% | +16.7% |
| Q1 2014 | $4,711,000 | +15.0% | 64,400 | +8.2% | 0.02% | +14.3% |
| Q4 2013 | $4,098,000 | -23.3% | 59,500 | -29.3% | 0.02% | -30.0% |
| Q3 2013 | $5,345,000 | -15.3% | 84,100 | -35.7% | 0.03% | -16.7% |
| Q2 2013 | $6,313,000 | – | 130,700 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Quinn Opportunity Partners LLC | 328,000 | $33,013,000 | 15.74% |
| Cheyne Capital Management (UK) LLP | 373,372 | $37,593,000 | 9.88% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 897,136 | $90,296,000 | 9.71% |
| Andromeda Capital LLC | 76,760 | $7,726,000 | 9.71% |
| Palo Alto Investors LP | 1,303,668 | $131,214,000 | 7.70% |
| Andromeda Capital LLC | 50,000 | $5,033,000 | 6.32% |
| QVT Financial LP | 1,200,000 | $120,780,000 | 6.04% |
| HARVEST MANAGEMENT LLC | 42,500 | $4,278,000 | 6.03% |
| Sandell Investment Services LLC | 58,525 | $5,891,000 | 5.62% |
| Kellner Capital, LLC | 70,200 | $7,066,000 | 4.83% |